Published in Epilepsia on March 12, 2009
A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci (2011) 3.23
Nearly automatic segmentation of hippocampal subfields in in vivo focal T2-weighted MRI. Neuroimage (2010) 2.03
Mesial temporal lobe epilepsy: How do we improve surgical outcome? Ann Neurol (2010) 1.32
Patterns of altered cortical perfusion and diminished subcortical integrity in posttraumatic stress disorder: an MRI study. Neuroimage (2010) 1.30
Hippocampal CA1 apical neuropil atrophy and memory performance in Alzheimer's disease. Neuroimage (2012) 1.11
Quantitative MRI in refractory temporal lobe epilepsy: relationship with surgical outcomes. Quant Imaging Med Surg (2015) 1.02
Network-level analysis of cortical thickness of the epileptic brain. Neuroimage (2010) 0.99
Measuring longitudinal change in the hippocampal formation from in vivo high-resolution T2-weighted MRI. Neuroimage (2012) 0.91
Bilateral hippocampal atrophy in temporal lobe epilepsy: effect of depressive symptoms and febrile seizures. Epilepsia (2011) 0.86
Gray matter loss correlates with mesial temporal lobe neuronal hyperexcitability inside the human seizure-onset zone. Epilepsia (2011) 0.85
Different structural correlates for verbal memory impairment in temporal lobe epilepsy with and without mesial temporal lobe sclerosis. Hum Brain Mapp (2011) 0.85
Predictive value of hippocampal internal architecture asymmetry in temporal lobe epilepsy. Epilepsy Res (2013) 0.85
Widespread extrahippocampal NAA/(Cr+Cho) abnormalities in TLE with and without mesial temporal sclerosis. J Neurol (2010) 0.85
Evidence for brainstem network disruption in temporal lobe epilepsy and sudden unexplained death in epilepsy. Neuroimage Clin (2014) 0.83
Heterogeneity of functional activation during memory encoding across hippocampal subfields in temporal lobe epilepsy. Neuroimage (2011) 0.82
Quantitative Neuroimaging Software for Clinical Assessment of Hippocampal Volumes on MR Imaging. J Alzheimers Dis (2015) 0.82
Evaluating hippocampal internal architecture on MRI: inter-rater reliability of a proposed scoring system. Epilepsy Res (2013) 0.81
MRI segmentation analysis in temporal lobe and idiopathic generalized epilepsy. BMC Neurol (2014) 0.80
Impact of methodologic choice for automatic detection of different aspects of brain atrophy by using temporal lobe epilepsy as a model. AJNR Am J Neuroradiol (2011) 0.80
Heritability of subcortical volumetric traits in mesial temporal lobe epilepsy. PLoS One (2013) 0.79
Delineation of hippocampal subregions using T1-weighted magnetic resonance images at 3 Tesla. Brain Struct Funct (2014) 0.77
Robust imaging of hippocampal inner structure at 7T: in vivo acquisition protocol and methodological choices. MAGMA (2016) 0.77
Amyloid in dementia associated with familial FTLD: not an innocent bystander. Neurocase (2015) 0.76
Automated subfield volumetric analysis of hippocampus in temporal lobe epilepsy using high-resolution T2-weighed MR imaging. Neuroimage Clin (2016) 0.76
Summary of the 2016 Partners Against Mortality in Epilepsy (PAME) Conference. Epilepsy Curr (2017) 0.75
A two-level multimodality imaging Bayesian network approach for classification of partial epilepsy: preliminary data. Neuroimage (2013) 0.75
Temporal lobe volume predicts Wada memory test performance in patients with mesial temporal sclerosis. Epilepsy Res (2015) 0.75
Hippocampal body changes in pure partial onset sleep and pure partial onset waking epileptic patients. Neurol Sci (2013) 0.75
Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron (2002) 33.99
Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease. Lancet (1994) 3.67
Measurement of hippocampal subfields and age-related changes with high resolution MRI at 4T. Neurobiol Aging (2006) 2.48
Temporal lobe volumetric cell densities in temporal lobe epilepsy. Epilepsia (1984) 2.21
A new clinico-pathological classification system for mesial temporal sclerosis. Acta Neuropathol (2007) 1.77
A retrospective analysis of hippocampal pathology in human temporal lobe epilepsy: evidence for distinctive patient subcategories. Epilepsia (2003) 1.73
Three-dimensional preoperative maps of hippocampal atrophy predict surgical outcomes in temporal lobe epilepsy. Neurology (2005) 1.69
Optimizing the diagnosis of hippocampal sclerosis using MR imaging. AJNR Am J Neuroradiol (1993) 1.57
Selective effect of Apo e4 on CA3 and dentate in normal aging and Alzheimer's disease using high resolution MRI at 4 T. Neuroimage (2008) 1.49
The clinical-pathogenic mechanisms of hippocampal neuron loss and surgical outcomes in temporal lobe epilepsy. Brain (1995) 1.47
Epilepsy and neuron loss in the hippocampus. Epilepsia (1980) 1.32
High resolution MRI of the brain at 4.7 Tesla using fast spin echo imaging. Br J Radiol (2003) 1.32
High-resolution fast spin echo imaging of the human brain at 4.7 T: implementation and sequence characteristics. Magn Reson Med (2004) 1.30
Hippocampal sclerosis without detectable hippocampal atrophy. Neurology (1994) 1.28
Stress, depression and hippocampal apoptosis. CNS Neurol Disord Drug Targets (2006) 1.24
Entorhinal cortex atrophy in epilepsy patients exhibiting normal hippocampal volumes. Neurology (2001) 1.22
PROPELLER MRI visualizes detailed pathology of hippocampal sclerosis. Epilepsia (2007) 1.11
Hippocampal deformation-based shape analysis in epilepsy and unilateral mesial temporal sclerosis. Epilepsia (2003) 0.95
Severe epilepsy: diagnostic and epidemiological aspects. Acta Neurol Scand Suppl (1988) 0.92
Hippocampal deformation mapping in MRI negative PET positive temporal lobe epilepsy. J Neurol Neurosurg Psychiatry (2007) 0.91
Predictive value of hippocampal MR imaging-based high-dimensional mapping in mesial temporal epilepsy: preliminary findings. AJNR Am J Neuroradiol (2006) 0.89
Hippocampal MRI volumetrics and temporal lobe substrates in medial temporal lobe epilepsy. Magn Reson Imaging (1995) 0.84
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol (2010) 19.42
The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging (2008) 14.68
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol (2013) 9.43
Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement (2005) 7.90
Mutant PIK3CA promotes cell growth and invasion of human cancer cells. Cancer Cell (2005) 7.87
The Alzheimer's disease neuroimaging initiative. Neuroimaging Clin N Am (2005) 7.26
Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol (2004) 7.07
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia (2010) 5.64
Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cells. Science (2009) 5.31
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol (2010) 5.03
Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease. Brain (2010) 4.39
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging (2009) 3.97
Longitudinal stability of MRI for mapping brain change using tensor-based morphometry. Neuroimage (2006) 3.85
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects. Neuroimage (2008) 3.40
Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia. J Magn Reson Imaging (2002) 3.34
Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. Neuroimage (2010) 3.27
Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology (2005) 3.14
Clinical Core of the Alzheimer's Disease Neuroimaging Initiative: progress and plans. Alzheimers Dement (2010) 3.11
Neuroanatomical correlates of behavioural disorders in dementia. Brain (2005) 2.92
Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative. Alzheimers Dement (2010) 2.88
The role of biomarkers in clinical trials for Alzheimer disease. Alzheimer Dis Assoc Disord (2006) 2.86
A frequent kinase domain mutation that changes the interaction between PI3Kalpha and the membrane. Proc Natl Acad Sci U S A (2009) 2.85
Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Ann Neurol (2012) 2.84
Evidence for ordering of Alzheimer disease biomarkers. Arch Neurol (2011) 2.83
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Neuroimage (2009) 2.80
Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans. Alzheimers Dement (2010) 2.79
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol (2012) 2.75
Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain (2007) 2.72
Neuropathological basis of magnetic resonance images in aging and dementia. Ann Neurol (2008) 2.71
Voxelwise genome-wide association study (vGWAS). Neuroimage (2010) 2.69
Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects. Alzheimers Dement (2010) 2.68
Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol (2006) 2.62
Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease. Brain (2009) 2.61
Longitudinal change of biomarkers in cognitive decline. Arch Neurol (2011) 2.51
3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage (2008) 2.40
The genome and transcriptomes of the anti-tumor agent Clostridium novyi-NT. Nat Biotechnol (2006) 2.31
Validation of a fully automated 3D hippocampal segmentation method using subjects with Alzheimer's disease mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.30
Structural anatomy of empathy in neurodegenerative disease. Brain (2006) 2.28
Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects. Neuroimage (2009) 2.28
Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Hum Brain Mapp (2009) 2.28
Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol (2006) 2.27
Neuropsychological dysfunction and neuroimaging abnormalities in neurologically intact adults with sickle cell anemia. JAMA (2010) 2.25
Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage (2008) 2.25
Boosting power for clinical trials using classifiers based on multiple biomarkers. Neurobiol Aging (2010) 2.13
A commonly carried allele of the obesity-related FTO gene is associated with reduced brain volume in the healthy elderly. Proc Natl Acad Sci U S A (2010) 2.12
White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain (2009) 2.08
Selective effect of age, Apo e4, and Alzheimer's disease on hippocampal subfields. Hippocampus (2009) 2.08
Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol Aging (2010) 2.05
Correlates of hippocampal neuron number in Alzheimer's disease and ischemic vascular dementia. Ann Neurol (2005) 2.05
Nearly automatic segmentation of hippocampal subfields in in vivo focal T2-weighted MRI. Neuroimage (2010) 2.03
Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage (2009) 2.03
Genome-wide analysis reveals novel genes influencing temporal lobe structure with relevance to neurodegeneration in Alzheimer's disease. Neuroimage (2010) 1.94
Intensity non-uniformity correction using N3 on 3-T scanners with multichannel phased array coils. Neuroimage (2007) 1.93
Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer's disease. Brain (2013) 1.91
The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav (2014) 1.90
Developing an international network for Alzheimer research: The Dominantly Inherited Alzheimer Network. Clin Investig (Lond) (2012) 1.90
Longitudinal MRI and cognitive change in healthy elderly. Neuropsychology (2007) 1.88
Body mass index and magnetic resonance markers of brain integrity in adults. Ann Neurol (2008) 1.88
Clinicopathological correlations in corticobasal degeneration. Ann Neurol (2011) 1.86
Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden. Brain (2010) 1.86
Age effects on atrophy rates of entorhinal cortex and hippocampus. Neurobiol Aging (2005) 1.83
The dynamics of cortical and hippocampal atrophy in Alzheimer disease. Arch Neurol (2011) 1.79
Imaging markers for Alzheimer disease: which vs how. Neurology (2013) 1.76
Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. Neuroimage (2012) 1.76
Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative. Arch Neurol (2011) 1.75
Posterior cingulate glucose metabolism, hippocampal glucose metabolism, and hippocampal volume in cognitively normal, late-middle-aged persons at 3 levels of genetic risk for Alzheimer disease. JAMA Neurol (2013) 1.75
Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: tissue-specific intensity normalization and parameter selection. Neuroimage (2009) 1.71
Targeting vascular and avascular compartments of tumors with C. novyi-NT and anti-microtubule agents. Cancer Biol Ther (2004) 1.71
3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol Aging (2010) 1.70
Genetic inactivation of AKT1, AKT2, and PDPK1 in human colorectal cancer cells clarifies their roles in tumor growth regulation. Proc Natl Acad Sci U S A (2010) 1.70
Obesity is linked with lower brain volume in 700 AD and MCI patients. Neurobiol Aging (2010) 1.69
Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals. Neuroimage (2010) 1.69
Perioperative cognitive decline in the aging population. Mayo Clin Proc (2011) 1.66
Selective disruption of the cerebral neocortex in Alzheimer's disease. PLoS One (2010) 1.65
Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci U S A (2005) 1.65
Voxel-based optimized morphometry (VBM) of gray and white matter in temporal lobe epilepsy (TLE) with and without mesial temporal sclerosis. Epilepsia (2006) 1.65
Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls. Neuroimage (2009) 1.63
Bacteriolytic therapy can generate a potent immune response against experimental tumors. Proc Natl Acad Sci U S A (2004) 1.63
Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.58
Automated MRI-based classification of primary progressive aphasia variants. Neuroimage (2009) 1.55
Comparing 3 T and 1.5 T MRI for tracking Alzheimer's disease progression with tensor-based morphometry. Hum Brain Mapp (2010) 1.55
Age-related glutamate and glutamine concentration changes in normal human brain: 1H MR spectroscopy study at 4 T. Neurobiol Aging (2005) 1.55
Characterizing Alzheimer's disease using a hypometabolic convergence index. Neuroimage (2011) 1.54
Magnetic resonance imaging of hippocampal subfields in posttraumatic stress disorder. Arch Gen Psychiatry (2010) 1.54
Comparison of phantom and registration scaling corrections using the ADNI cohort. Neuroimage (2009) 1.53
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci (2011) 1.51
Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging. Neuroimage Clin (2013) 1.49
Voxelwise gene-wide association study (vGeneWAS): multivariate gene-based association testing in 731 elderly subjects. Neuroimage (2011) 1.48
Chronic active heavy drinking and family history of problem drinking modulate regional brain tissue volumes. Psychiatry Res (2005) 1.47
17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. Arch Neurol (2004) 1.47
Hippocampal atrophy patterns in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp (2010) 1.47
Human brain: reliability and reproducibility of pulsed arterial spin-labeling perfusion MR imaging. Radiology (2005) 1.45
A tensor based morphometry study of longitudinal gray matter contraction in FTD. Neuroimage (2007) 1.45
Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. Neuroimage (2010) 1.45
Shapes of the trajectories of 5 major biomarkers of Alzheimer disease. Arch Neurol (2012) 1.44